PUNWATTIE RAMNARAINE: Open Payments
NPI 1831573286 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 15 payments from 9 companies in 2025. Trend: 2023 $394 · 2024 $339 · 2025 $342
Food & beverage: $342
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $121 |
| Amgen Inc. | 3 | $59 |
| Boston Scientific Corporation | 1 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Novo Nordisk Inc | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, OTEZLA, WATCHMAN FLX, REXULTI, EVKEEZA, Ozempic, JOURNAVX, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
